Unknown OBSERVATIONAL NCT05507034

Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment. (sCANsens)

sCANsens: Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment

Sponsor: Fund for Scientific Research, Flanders, Belgium

Conditions Carcinoma Breast Chronic Pain Neoplasm, Breast

Interventions Biomarkers

Updated 5 times since 2022 Last updated: Dec 20, 2023 Started: Oct 4, 2022 Primary completion: Jun 30, 2025 Completion: Jun 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Carcinoma Breast and Chronic Pain and is currently ongoing. Fund for Scientific Research, Flanders, Belgium leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Jan 2026 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Jan 2026 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jan 2024 — Jul 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Sep 2022 — Jan 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fund for Scientific Research, Flanders, Belgium
Universiteit Antwerpen
University Hospital, Antwerp

Data source: Universiteit Antwerpen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Wilrijk, Belgium